Corcept Therapeutics
CORT
#2085
Rank
$9.13 B
Marketcap
$86.70
Share price
1.64%
Change (1 day)
47.43%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: $9.13 Billion USD

As of December 2025 Corcept Therapeutics has a market cap of $9.13 Billion USD. This makes Corcept Therapeutics the world's 2085th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025$9.13 B66.19%
2024$5.49 B64.2%
2023$3.34 B53.13%
2022$2.18 B-4.36%
2021$2.28 B-24.78%
2020$3.03 B119.26%
2019$1.38 B-9.81%
2018$1.53 B-25.44%
2017$2.06 B155.69%
2016$0.80 B47.63%
2015$0.54 B79.5%
2014$0.30 B-5.1%
2013$0.32 B124.55%
2012$0.14 B-50.45%
2011$0.28 B3.07%
2010$0.27 B60.92%
2009$0.17 B242.17%
2008$50.75 M-58.46%
2007$0.12 B286.1%
2006$31.65 M-61.7%
2005$82.64 M-41.6%
2004$0.14 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Corcept Therapeutics was reported to be:

$8.97 Billion USD
by Nasdaq info icon info icon
$8.98 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
$506.02 B 5,438.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$104.07 B 1,039.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$255.41 B 2,695.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$914.56 B 9,910.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$146.66 B 1,505.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$246.95 B 2,603.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.92 B-89.83%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$1.78 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$10.36 B 13.43%๐Ÿ‡บ๐Ÿ‡ธ USA